O. Mete Et Al. , "Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis," VIRCHOWS ARCHIV , vol.447, no.6, pp.938-946, 2005
Mete, O. Et Al. 2005. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. VIRCHOWS ARCHIV , vol.447, no.6 , 938-946.
Mete, O., Kilicaslan, I., Gulluoglu, M., & Uysal, V., (2005). Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. VIRCHOWS ARCHIV , vol.447, no.6, 938-946.
Mete, O Et Al. "Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis," VIRCHOWS ARCHIV , vol.447, no.6, 938-946, 2005
Mete, O Et Al. "Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis." VIRCHOWS ARCHIV , vol.447, no.6, pp.938-946, 2005
Mete, O. Et Al. (2005) . "Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis." VIRCHOWS ARCHIV , vol.447, no.6, pp.938-946.
@article{article, author={O Mete Et Al. }, title={Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis}, journal={VIRCHOWS ARCHIV}, year=2005, pages={938-946} }